Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
As of 2026-04-13, The Beauty Health Company (SKIN) trades at a current price of $0.88, marking a 1.54% decline from the previous session’s close. This analysis evaluates key technical levels, recent sector context, and potential short-term price scenarios for SKIN, with no company-specific material news driving price action in recent sessions. No recent earnings data is available for the company at the time of writing, so near-term price movements are primarily tied to technical trading patterns
Is The Beauty (SKIN) Stock in a Selling Zone | Price at $0.88, Down 1.54% - Analyst Upgrade
SKIN - Stock Analysis
3205 Comments
1485 Likes
1
Fatimah
Returning User
2 hours ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
👍 228
Reply
2
Shamara
New Visitor
5 hours ago
Active rotation between sectors highlights the ongoing need for careful stock selection and diversification.
👍 67
Reply
3
Indika
Expert Member
1 day ago
Who else is curious about this?
👍 57
Reply
4
Kiril
Power User
1 day ago
Explains trends clearly without overcomplicating the topic.
👍 155
Reply
5
Elyza
Regular Reader
2 days ago
I really wish I had come across this earlier, would’ve changed my decision.
👍 291
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.